Stock 2CUREX 2CUREX AB
Add to a list
To use this feature you must be a member
Log inSign up

Other languages 2cureX AB

Equities

2CUREX

SE0010468124

Market Closed - Nasdaq Stockholm
Other stock markets
 15:15:54 03/05/2024 BST 		5-day change 1st Jan Change
0.404 SEK -16.53% Intraday chart for 2cureX AB -9.42% -79.90%
02-29 2curex AB Elects Grith Hagel as a New Board Member CI
02-22 2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
2curex AB Elects Grith Hagel as a New Board Member
2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2023
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
2cureX AB Announces Change to the Board of Directors
2cureX AB Announces CEO Changes
2cureX AB Announces Executive Changes, Effective 1 January 2024
2cureX Makes Executive Changes Amid Planned Global Expansion of IndiTreat Tests; Shares Drop
2cureX AB Receives Ethical Approval for HIPEC Clinical Trial
2cureX AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
2Curex AB Appoints Tonni Bülow-Nielsen as Board Member and Chairman
2cureX Announces to Focus All Resources on Making IndiTreat Testing Available at Hospitals Worldwide by Accelerating the Development of an Automated IVD System
2cureX Signs Contract with Notified Body in EU for Certification of Cancer Tests
2curex Launches Its First Two IndiTreat® Products Ce-Marked Under the New Ivd Regulation
2cureX AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
2cureX AB Reports Earnings Results for the First Quarter Ended March 31, 2023
2cureX AB Provides Sales Guidance for Second Quarter
2cureX Announces Launch of Updated Specimen Collection Set
2cureX AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
2cureX AB Reports Earnings Results for the Full Year Ended December 31, 2022
2cureX AB Appoints Michel Klimkeit to Board of Director
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2CUREX Stock
  4. News 2cureX AB
  5. Other languages